ERBB4 and neuroblastoma: In neuroblastoma, the ErbB tyrosine kinases, such as EGFR and ERBB4, have been reported to promote cell growth and prevent apoptosis in preclinical models via the MAPK–ERK and PI3K–AKT49–51 pathways.